Chemomab Therapeutics's total assets for Q4 2023 were $22.15M, a decrease of -36.73% from the previous quarter. CMMB total liabilities were $5.15M for the fiscal quarter, a -26.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.